Gilcrease MZ - Search Results

1

Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.

Khalifeh I, Deavers MT, Cristofanilli M, Coleman RL, Malpica A, Gilcrease MZ. Khalifeh I, et al. Among authors: gilcrease mz. Breast J. 2009 Mar-Apr;15(2):176-81. doi: 10.1111/j.1524-4741.2009.00693.x. Breast J. 2009. PMID: 19292804

2

CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.

Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, Sneige N, Sahin A, Gilcrease MZ. Diaz LK, et al. Among authors: gilcrease mz. Clin Cancer Res. 2005 May 1;11(9):3309-14. doi: 10.1158/1078-0432.CCR-04-2184. Clin Cancer Res. 2005. PMID: 15867228

3

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.

Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Huo L, et al. Among authors: gilcrease mz. Histopathology. 2013 Jan;62(2):267-74. doi: 10.1111/j.1365-2559.2012.04344.x. Epub 2012 Sep 11. Histopathology. 2013. PMID: 22963676 Free PMC article.

4

Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer.

Diaz LK, Cristofanilli M, Zhou X, Welch KL, Smith TL, Yang Y, Sneige N, Sahin AA, Gilcrease MZ. Diaz LK, et al. Among authors: gilcrease mz. Mod Pathol. 2005 Sep;18(9):1165-75. doi: 10.1038/modpathol.3800411. Mod Pathol. 2005. PMID: 15920552 Free article.

5

GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.

Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. Huo L, et al. Among authors: gilcrease mz. Histopathology. 2015 Aug;67(2):245-54. doi: 10.1111/his.12645. Epub 2015 Feb 23. Histopathology. 2015. PMID: 25564996

6

Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.

Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX. Esteva FJ, et al. Among authors: gilcrease mz. Clin Cancer Res. 2003 Nov 15;9(15):5652-9. Clin Cancer Res. 2003. PMID: 14654548

7

An unusual presentation of locally recurrent breast cancer: a case report.

Izaddoost S, Boughey JC, Williams SA, Gilcrease M, Ames F. Izaddoost S, et al. Breast J. 2007 May-Jun;13(3):294-6. doi: 10.1111/j.1524-4741.2007.00425.x. Breast J. 2007. PMID: 17461906

8

Breast carcinoma with neuroendocrine differentiation and myocardial metastases.

Hennessy BT, Gilcrease MZ, Kim E, Gonzalez-Angulo AM. Hennessy BT, et al. Among authors: gilcrease mz. Clin Breast Cancer. 2007 Dec;7(11):892-4. doi: 10.3816/CBC.2007.n.056. Clin Breast Cancer. 2007. PMID: 18269781

9

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.

Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL Jr, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ. Lester TR, et al. Among authors: gilcrease mz. Breast Cancer Res Treat. 2012 Jan;131(1):41-8. doi: 10.1007/s10549-011-1393-6. Epub 2011 Feb 18. Breast Cancer Res Treat. 2012. PMID: 21331622 Free PMC article.

10

Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.

Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, Valero V, Hortobagyi G, Atchley D, Arun B. Yang WT, et al. Breast Cancer Res Treat. 2008 Oct;111(3):405-10. doi: 10.1007/s10549-007-9810-6. Epub 2007 Nov 17. Breast Cancer Res Treat. 2008. PMID: 18026834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page